Practical compliance and inspection readiness for UK pharmaceutical quality systems

Is your pharmaceutical quality system receiving the scrutiny it needs?

About this Webinar

Keeping pace with the evolving regulatory environment means that pharmaceutical and biotech organisations must maintain a quality system that is resilient during close scrutiny from authorities such as the MHRA, EMA and FDA.

In this UK focused session, delivered in collaboration with our partner Scilife, Angel Buendía, Pharmaceutical Quality and CMC Expert and Consultant, together with Christopher Homan, Rephine consultant, will share practical guidance tailored to growing and mid sized organisations. The session will explore current inspection behaviours, common compliance challenges and actionable ways to strengthen inspection readiness while keeping quality processes simple and effective.

The session will cover the following topics

UK and EU regulatory expectations and how they shape your quality system
Essential PQS considerations for expanding pharmaceutical and biotech teams
Current inspection trends from the MHRA, FDA and EMA, including data integrity focus points
Practical methods to maintain inspection readiness
Best practices for managing responses and preventing post inspection escalation